Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
No news for this category today.
----------------------------------------------
** CANCER / ONCOLOGY News **
FDA Allows Phase 2 Study For Sound Pharmaceuticals' Novel Drug To Prevent Chemotherapy Induced Hearing Loss
http://www.medicalnewstoday.com/articles/117759.php
Sound Pharmaceuticals (SPI) has received FDA notification that it may proceed with its Phase II study to prevent chemotherapy induced hearing loss. The Ph-II study will enroll 80 patients with advanced head and neck, and non-small cell lung cancer at the National Center for Rehabilitative Auditory Research at the Veterans Administration Hospital and the Oregon Health and Science University in Portland, Oregon.
Management Of The Small Renal Mass
http://www.medicalnewstoday.com/articles/117598.php
Small renal masses are defined as stage T1a lesions (less than 4cm), but certainly lesions less than 2cm fall into this definition. There is a 126% increase in the detection of renal cell cancers since 1950, due to increased imaging and incidental detection of renal masses.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Intrabone Administration Of Unrelated Cord-Blood Cells Is Successful In Enabling More Patients With Acute Leukaemia To Undergo Transplantation
http://www.medicalnewstoday.com/articles/117780.php
Intrabone administration of unrelated umbilical-cord-blood cells overcomes the problem of graft failure seen with intravenous administration and is associated with a low incidence of graft-versus-host disease*, making the technique potentially useful in a large number of adult patients with acute leukaemia, according to findings from a phase I/II study, published early <b>Online</b> and in the September edition of <i>The Lancet Oncology</i>.
GlaxoSmithKline And Genmab Announce Positive Top-line Results In Ofatumumab Chronic Lymphocytic Leukaemia Pivotal Study
http://www.medicalnewstoday.com/articles/117771.php
GlaxoSmithKline (LSE and NYSE: GSK) and Genmab A/S (OMX: GEN) announced today positive top-line results from an interim analysis of the Phase III pivotal study evaluating ofatumumab (HuMax-CD20®) in two difficult to treat groups of patients with chronic lymphocytic leukaemia (CLL).
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Salvage Options For Biochemical Recurrence After Primary Therapy For Prostate Cancer
http://www.medicalnewstoday.com/articles/117779.php
UroToday.com - Despite excellent success rates with radical prostatectomy and radiotherapy for the treatment of prostate cancer, a significant number of patients will experience a rise in their serum prostate specific antigen (PSA) level.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment